The role of hemoperfusion in COVID-19

Phase 2

Recruiting

• Conditions: COVID-19.; COVID-19; U07.1

• Registration Number: IRCT20200608047686N2
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 November 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Hospitalized patients with respiratory failure caused by the COVID-19

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
O2 Saturation. Timepoint: Before and after the sessions of hemoperfusion. Method of measurement: Pulse Oximetry.;CRP. Timepoint: Before and after the sessions of hemoperfusion. Method of measurement: Blood level.;Ferritin. Timepoint: Before and after the sessions of hemoperfusion. Method of measurement: Blood level.;Vasopressor need. Timepoint: Before and after the sessions of hemoperfusion. Method of measurement: Observation.

Secondary Outcome Measures

Name	Time	Method
enght of hospitat stay. Timepoint: Daily up to discharge. Method of measurement: Days of hospitalization.;Mortality. Timepoint: Daily up to 28 days. Method of measurement: Observation.